We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01198522
Recruitment Status : Terminated (lack of recruitment)
First Posted : September 10, 2010
Last Update Posted : November 20, 2014
Information provided by (Responsible Party):
Philogen S.p.A.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : November 2014
  Study Completion Date : November 2014